How to report pathological indicators of gastric malignancies in a hospital in Iran, a developing country
Report pathological indicators in gastric malignancies
,
Abstract
Background: The aim this study was How to report pathological indicators of gastric malignancies in a hospital in Iran, a developing country. Methods: This cross-sectional study was conducted on 174 patients. Study variables including age and sex, type of biopsy, extent of gastric tissue involvement, exact anatomical location, tumor size, histological grading, invasion of surrounding tissues and lymph node metastasis were extracted from patients' records. Data were analyzed using SPSS 22 software. Frequency and percentage were reported using descriptive statistics. Graphs were drawn using Excel 2010. Results: 174 patients were studied in this study; that 63.8% of the patients were female (n= 111). The prevalent of reports were related to the histology of adenocarcinoma (n = 136, p = 78.20), tumor size (n = 89, p = 51.15), anatomical exact location (n = 90, p = 51.70), respectively. Among the 90 patients for whom the exact anatomical location was reported, the most reports were related to the antrum (n = 38, p = 42.23). The highest prevalence of histological type of adenocarcinoma was related to Poorly differentiated (n = 57, p = 41.94). Conclusion: The findings of this study showed that the way of reporting pathological indicators in gastric malignancies in the studied cases was somewhat appropriate.
1. Papaxoinis G, Papageorgiou S, Rontogianni D, Kaloutsi V, Fountzilas G, Pavlidis N, et al. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leukemia & lymphoma. 2006;47(10):2140-6.
2. Liu Q, Zeng X, Wang W, Huang R-l, Huang Y-j, Liu S, et al. Awareness of risk factors and warning symptoms and attitude towards gastric cancer screening among the general public in China: a cross-sectional study. BMJ open. 2019;9(7):e029638.
3. Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World journal of gastroenterology: WJG. 2014;20(38):13842.
4. Virmani V, Khandelwal A, Sethi V, Fraser-Hill M, Fasih N, Kielar A. Neoplastic stomach lesions and their mimickers: spectrum of imaging manifestations. Cancer Imaging. 2012;12(1):269.
5. He Y-T, Hou J, Chen Z-F, Qiao C-Y, Song G-H, Meng F-S, et al. Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. European Journal of Cancer Prevention. 2008;17(2):71-6.
6. Yusefi AR, Lankarani KB, Bastani P, Radinmanesh M, Kavosi Z. Risk factors for gastric cancer: a systematic review. Asian Pacific journal of cancer prevention: APJCP. 2018;19(3):591.
7. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences. 2020;21(11):4012.
8. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88(4):921-32.
9. Bray F, Ferlay J, Laversanne M, Brewster D, Gombe Mbalawa C, Kohler B, et al. Cancer I ncidence in F ive C ontinents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. International journal of cancer. 2015;137(9):2060-71.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. 2010;127(12):2893-917.
11. Etemadi A, Safiri S, Sepanlou SG, Ikuta K, Bisignano C, Shakeri R, et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. The Lancet Gastroenterology & Hepatology. 2020;5(1):42-54.
12. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T, et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Japanese Journal of Clinical Oncology. 2011;41(1):40-51.
13. Jun JK, Choi KS, Lee H-Y, Suh M, Park B, Song SH, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology. 2017;152(6):1319-28. e7.
14. Williams J, Quirke P, Shepherd N. Dataset for Colorectal Cancer. 2nd edn. London: The Royal College of Pathologists, 2007.(Updated September 2007).
15. King P, Blazeby J, Gupta J, Alderson D, Moorghen M. Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets. Journal of clinical pathology. 2004;57(7):702-5.
16. Rafiemanesh H, Rajaei-Behbahani N, Khani Y, Hosseini S. Incidence trend and epidemiology of common cancers in the center of Iran. Global journal of health science. 2016;8(3):146.
17. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Annals of oncology. 2009;20(3):556-63.
18. Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iranian journal of public health. 2018;47(3):309.
19. Akhavan A. Audit of Gastric Cancer Pathology Reports in Yazd. 2011.
20. Bull A, Biffin A, Mella J, Radcliffe A, Stamatakis J, Steele R, et al. Colorectal cancer pathology reporting: a regional audit. Journal of clinical pathology. 1997;50(2):138-42.
21. Hashemi S, Hagh-Azali M, Bagheri M, Kabir A. Histopathologic and Anatomic Correlation ofPrimary Gastric Cancers. Razi Journal of Medical Sciences. 2004;11(40):319-26.
22. Nourozinia F, Rasmi Y, Otarod M, Golizadeh M, Khadem-Ansari M-H. Epidemiology and histopathology of gastric cancer in Urmia. Urmia Medical Journal. 2013;24(3):170-5.
2. Liu Q, Zeng X, Wang W, Huang R-l, Huang Y-j, Liu S, et al. Awareness of risk factors and warning symptoms and attitude towards gastric cancer screening among the general public in China: a cross-sectional study. BMJ open. 2019;9(7):e029638.
3. Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World journal of gastroenterology: WJG. 2014;20(38):13842.
4. Virmani V, Khandelwal A, Sethi V, Fraser-Hill M, Fasih N, Kielar A. Neoplastic stomach lesions and their mimickers: spectrum of imaging manifestations. Cancer Imaging. 2012;12(1):269.
5. He Y-T, Hou J, Chen Z-F, Qiao C-Y, Song G-H, Meng F-S, et al. Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. European Journal of Cancer Prevention. 2008;17(2):71-6.
6. Yusefi AR, Lankarani KB, Bastani P, Radinmanesh M, Kavosi Z. Risk factors for gastric cancer: a systematic review. Asian Pacific journal of cancer prevention: APJCP. 2018;19(3):591.
7. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences. 2020;21(11):4012.
8. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88(4):921-32.
9. Bray F, Ferlay J, Laversanne M, Brewster D, Gombe Mbalawa C, Kohler B, et al. Cancer I ncidence in F ive C ontinents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. International journal of cancer. 2015;137(9):2060-71.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. 2010;127(12):2893-917.
11. Etemadi A, Safiri S, Sepanlou SG, Ikuta K, Bisignano C, Shakeri R, et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. The Lancet Gastroenterology & Hepatology. 2020;5(1):42-54.
12. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T, et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Japanese Journal of Clinical Oncology. 2011;41(1):40-51.
13. Jun JK, Choi KS, Lee H-Y, Suh M, Park B, Song SH, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology. 2017;152(6):1319-28. e7.
14. Williams J, Quirke P, Shepherd N. Dataset for Colorectal Cancer. 2nd edn. London: The Royal College of Pathologists, 2007.(Updated September 2007).
15. King P, Blazeby J, Gupta J, Alderson D, Moorghen M. Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets. Journal of clinical pathology. 2004;57(7):702-5.
16. Rafiemanesh H, Rajaei-Behbahani N, Khani Y, Hosseini S. Incidence trend and epidemiology of common cancers in the center of Iran. Global journal of health science. 2016;8(3):146.
17. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Annals of oncology. 2009;20(3):556-63.
18. Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iranian journal of public health. 2018;47(3):309.
19. Akhavan A. Audit of Gastric Cancer Pathology Reports in Yazd. 2011.
20. Bull A, Biffin A, Mella J, Radcliffe A, Stamatakis J, Steele R, et al. Colorectal cancer pathology reporting: a regional audit. Journal of clinical pathology. 1997;50(2):138-42.
21. Hashemi S, Hagh-Azali M, Bagheri M, Kabir A. Histopathologic and Anatomic Correlation ofPrimary Gastric Cancers. Razi Journal of Medical Sciences. 2004;11(40):319-26.
22. Nourozinia F, Rasmi Y, Otarod M, Golizadeh M, Khadem-Ansari M-H. Epidemiology and histopathology of gastric cancer in Urmia. Urmia Medical Journal. 2013;24(3):170-5.
| Files | ||
| Issue | Vol 14 No 3 (2022) | |
| Section | Original Articles | |
| DOI | https://doi.org/10.18502/bccr.v14i3.14354 | |
| Keywords | ||
| pathological indicators gastric malignancies Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Ansari K, Moghimi M, Jafari M. How to report pathological indicators of gastric malignancies in a hospital in Iran, a developing country. Basic Clin Cancer Res. 2023;14(3):162-167.
